New buyers of PACS represent only a small minority of customers, according to IMV Medical Information Division.
New buyers of PACS represent only a small minority of customers, according to IMV Medical Information Division. The need to upgrade or replace systems is the primary driver in the PACS marketplace right now, with most purchases going for current-system upgrades.
Full-system purchases may make up only 13% of the planned expenditures for PACS from now through 2012, according to the market research firm. And of these, more than four of five purchases are to replace systems already in place.
With such a small percentage of PACS expenditures going to full systems, another 73% of the total expenditures are earmarked for expanding and upgrading present PACS, according to IMV.
Leading Breast Radiologists Discuss the USPSTF Breast Cancer Screening Recommendations
May 17th 2024In recognition of National Women’s Health Week, Dana Bonaminio, MD, Amy Patel, MD, and Stacy Smith-Foley, MD, shared their thoughts and perspectives on the recently updated breast cancer screening recommendations from the United States Preventive Services Task Force (USPSTF).
Multicenter CT Study Shows Benefits of Emerging Diagnostic Model for Clear Cell Renal Cell Carcinoma
May 15th 2024Combining clinical and CT features, adjunctive use of a classification and regression tree (CART) diagnostic model demonstrated AUCs for detecting clear cell renal cell carcinoma (ccRCC) that were 15 to 22 percent higher than unassisted radiologist assessments.
CT Study: AI Algorithm Comparable to Radiologists in Differentiating Small Renal Masses
May 14th 2024An emerging deep learning algorithm had a lower AUC and sensitivity than urological radiologists for differentiating between small renal masses on computed tomography (CT) scans but had a 21 percent higher sensitivity rate than non-urological radiologists, according to new research.